Paradoxically high rise in CD4 lymphocyte count in the immune reconstitution inflammatory syndrome in a patient with tuberculosis and HIV infection
https://doi.org/10.22328/2077-9828-2024-16-3-115-123
Abstract
The number of patients with HIV infection in the Russian Federation is increasing, which requires wider implementation of antiretroviral therapy and, accordingly, criteria for assessing its effectiveness.
Purpose of the study. To present for consideration a clinical case of tuberculosis combined with HIV infection, with a paradoxically high increase in the number of CD4 lymphocytes in the inflammatory syndrome of immune reconstitution, which does not meet the accepted criteria for assessing the effectiveness of treatment.
Materials and methods. Dynamic monitoring of the results of treatment of a patient with tuberculosis combined with HIV infection. Research methods: clinical, radiological, laboratory and microbiological.
Results and its discussion. In a patient with tuberculosis combined with HIV infection, a paradoxically high increase in the number of CD4 lymphocytes (15 times) is possible with inflammatory syndrome of immune restoration, followed by a sharp decrease.
Conclusion. Approaches to developing criteria for assessing the effectiveness of treatment for patients with tuberculosis combined with HIV infection require further research and additional recommendations.
About the Authors
V. S. BorovitskyRussian Federation
Moscow
Kirovo-Chepetsk
O. P. Frolova
Russian Federation
Moscow
References
1. Pokrovsky V.V., Yurin O.G., Kravchenko A.V. еt al. National recommendations for clinical observation and treatment of patients with HIV infection. Epidemiology and infectious diseases, current issues, 2017, No. 6, 80 pp. (In Russ.).
2. Lectures on HIV infection /edited by V. V. Pokrovsky. 2nd ed. reworked and additional. Moscow: Publishing house GEOTAR-Media, 2023. 848 p.: ill. (In Russ.).
3. Sereti I., Rodger A.J, French M.A. Biomarkers in immune reconstitution inflammatory syndrome: signals from pathogenesis // Curr. Opin. HIV AIDS. 2010. No. 5. P. 504–510.
4. French M.A., Mallal S.A., Dawkins R.L. Zidovudine-induced restoration of cell-mediated immunity to mycobacteria in immunodeficient HIV-infected patients // AIDS. 1992. No. 6. P. 1293–1297. doi: 10.1097/00002030-199211000-00009.
5. Namale P.E., Abdullahi L.H., Fine S., Kamkuemah M., Wilkinson R.J., Meintjes G. Paradoxical TB-IRIS in HIV-infected adults: a systematic review and meta-analysis // Future Microbiol. 2015. No. 10. P. 1077–1099. doi: 10.2217/fmb.15.9.
6. Van Rie A., Sawry S., Link-Gelles R., Madhi S., Fairlie L., Verwey C., Mahomed N., Murdoch D., Moultrie H. Paradoxical tuberculosis-associated immune reconstitution inflammatory syndrome in children // Pediatr. Pulmonol. 2016. No. 51. P. 157–164. doi: 10.1002/ppul.23221.
7. Michailidis C., Pozniak A.L., Mandalia S., Basnayake S., Nelson M.R., Gazzard B.G. Clinical characteristics of IRIS syndrome in patients with HIV and tuberculosis // Antivir. Ther. 2005. No. 10 (3). P. 417–422.
8. Chakrabarti L.A., Lortholary O. IRIS: a paradoxical inflammatory reaction in patients treated simultaneously for tuberculosis and HIV // Med. Sci. (Paris). 2015. No. 31 (1). P. 53–59.
9. Autran B., Carcelain G., Li T. S., Blanc C., Mathez D., Tubiana R., Katlama C., Debré P., Leibowitch J. Positive effects of combined antiretroviral therapy on CD4+T-cell homeostasis and function in advanced HIV disease // Science. 1997. No. 277 (5322). P. 112–116.
10. Fleury S., Rizzardi G.P., Chapuis A., Tambussi G., Knabenhans C., Simeoni E., Meuwly J.-Y., Corpataux J.-M., Lazzarin A., Miedema F., Pantaleo G. Long-term kinetics of T cell production in HIV-infected subjects treated with highly active antiretroviral therapy // Proc. Natl. Acad. Sci. U S A. 2000. Vol. 97, No. 10. P. 5393–5398.
11. Quinn C.M., Poplin V., Kasibante J., Yuquimpo K., Gakuru J., Cresswell F. V., Bahr N.C. Tuberculosis IRIS: Pathogenesis, Presentation, and Management across the Spectrum of Disease // Life (Basel). 2020. Vol. 10, No. 11. P. 262.
12. Tiburcio R., Narendran G., Barreto-Duarte B., Queiroz A.T.L., Araujo-Pereira M., Anbalagan S., Nayak K., Ravichandran N., Subramani R., Antonelli LRV., Satagopan K., Anbalagan K., Porter B. O., Sher A., Swaminathan S., Sereti I., Andrade B.B. Frequency of CXCR3+ CD8+TLymphocyte Subsets in Peripheral Blood Is Associated With the Risk of Paradoxical Tuberculosis-Associated Immune Reconstitution Inflammatory Syndrome Development in Advanced HIV Disease // Front. Immunol. 2022. No. 13. P. 873985. doi: 10.3389/fimmu.2022.873985.
13. Andrade B.B., Singh A., Narendran G., Schechter M.E., Nayak K., Subramanian S., Anbalagan S., Jensen S.M., Porter B.O., Antonelli L.R. et al. Mycobacterial antigen driven activation of CD14++CD16- monocytes is a predictor of tuberculosis-associated immune reconstitution inflammatory syndrome // PLoS Pathog. 2014. No. 10. P. e1004433.
14. Narendran G., Andrade B.B., Porter B.O., Chandrasekhar C., Venkatesan P., Menon P.A., Subramanian S., Anbalagan S., Bhavani K.P., Sekar S. et al. Paradoxical tuberculosis immune reconstitution inflammatory syndrome (TB-IRIS) in HIV patients with culture confirmed pulmonary tuberculosis in India and the potential role of IL-6 in prediction // PLoS One. 2013. No. 8. P. e63541.
15. Tan H.Y., Yong Y.K., Andrade B.B., Shankar E.M., Ponnampalavanar S., Omar S.F., Narendran G., Kamarulzaman A., Swaminathan S., Sereti I. et al. Plasma interleukin-18 levels are a biomarker of innate immune responses that predict and characterize tuberculosis-associated immune reconstitution inflammatory syndrome // AIDS. 2015. No. 29. P. 421–431.
Review
For citations:
Borovitsky V.S., Frolova O.P. Paradoxically high rise in CD4 lymphocyte count in the immune reconstitution inflammatory syndrome in a patient with tuberculosis and HIV infection. HIV Infection and Immunosuppressive Disorders. 2024;16(3):115-123. (In Russ.) https://doi.org/10.22328/2077-9828-2024-16-3-115-123